Launchcode - Mickelberg, Larry
15,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
8 °P sammeln
  • Broschiertes Buch

Volume 2: The Commercial AI Playbook reveals how AI agents are redefining the operating model of pharmaceutical commercialization. From omnichannel planning and brand strategy to insight generation and launch execution, Larry Mickelberg unpacks how agentic systems reinvent the daily workflows of modern commercial teams. This volume offers a practical blueprint for rebuilding the commercial stack-task by task, role by role-with intelligent agents at the core. For leaders of brand, field, and agency teams, it's a playbook for speed, adaptability, and competitive advantage in the era of AI-powered precision.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Volume 2: The Commercial AI Playbook reveals how AI agents are redefining the operating model of pharmaceutical commercialization. From omnichannel planning and brand strategy to insight generation and launch execution, Larry Mickelberg unpacks how agentic systems reinvent the daily workflows of modern commercial teams. This volume offers a practical blueprint for rebuilding the commercial stack-task by task, role by role-with intelligent agents at the core. For leaders of brand, field, and agency teams, it's a playbook for speed, adaptability, and competitive advantage in the era of AI-powered precision.
Autorenporträt
Larry Mickelberg is the founder and CEO of Axonal.AI, a company pioneering the use of agentic AI systems to transform pharmaceutical commercialization. A recognized leader in healthcare marketing and digital transformation, Larry has held senior executive roles at global consultancies and agency networks, including Publicis Health, Deloitte, and Havas. With more than two decades of experience advising life sciences companies on strategy, innovation, and technology adoption, he has been at the forefront of helping organizations modernize how therapies are launched and scaled globally. Larry's work now centers on building intelligent, secure AI workspaces that enable pharmaceutical teams and their agencies to move faster from data to actionable insight - reshaping the commercial operating model for the AI era.